179 related articles for article (PubMed ID: 37704951)
1. Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.
Onyango CO; Cheng Q; Munde EO; Raballah E; Anyona SB; McMahon BH; Lambert CG; Onyango PO; Schneider KA; Perkins DJ; Ouma C
BMC Genomics; 2023 Sep; 24(1):542. PubMed ID: 37704951
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.
Anyona SB; Hengartner NW; Raballah E; Ong'echa JM; Lauve N; Cheng Q; Fenimore PW; Ouma C; Lambert CG; McMahon BH; Perkins DJ
J Hum Genet; 2020 Jan; 65(2):99-113. PubMed ID: 31664161
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria.
Ong'echa JM; Raballah EO; Kempaiah PM; Anyona SB; Were T; Davenport GC; Konah S; Vulule JM; Ouma C; Hittner JB; Perkins DJ
BMC Genet; 2011 Aug; 12():69. PubMed ID: 21819616
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
Kisia LE; Kempaiah P; Anyona SB; Munde EO; Achieng AO; Ong'echa JM; Lambert CG; Chelimo K; Ouma C; Perkins DJ; Raballah E
BMC Med Genet; 2019 Aug; 20(1):140. PubMed ID: 31420016
[TBL] [Abstract][Full Text] [Related]
5. Haplotype of non-synonymous mutations within IL-23R is associated with susceptibility to severe malaria anemia in a P. falciparum holoendemic transmission area of Kenya.
Munde EO; Raballah E; Okeyo WA; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):291. PubMed ID: 28427357
[TBL] [Abstract][Full Text] [Related]
6. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.
Ouma C; Davenport GC; Garcia S; Kempaiah P; Chaudhary A; Were T; Anyona SB; Raballah E; Konah SN; Hittner JB; Vulule JM; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Feb; 131(2):289-99. PubMed ID: 21818580
[TBL] [Abstract][Full Text] [Related]
7. Nonsynonymous amino acid changes in the α-chain of complement component 5 influence longitudinal susceptibility to
Raballah E; Wilding K; Anyona SB; Munde EO; Hurwitz I; Onyango CO; Ayieko C; Lambert CG; Schneider KA; Seidenberg PD; Ouma C; McMahon BH; Cheng Q; Perkins DJ
Front Genet; 2022; 13():977810. PubMed ID: 36186473
[No Abstract] [Full Text] [Related]
8. Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya.
Kisia LE; Cheng Q; Raballah E; Munde EO; McMahon BH; Hengartner NW; Ong'echa JM; Chelimo K; Lambert CG; Ouma C; Kempaiah P; Perkins DJ; Schneider KA; Anyona SB
Trop Med Health; 2022 Jun; 50(1):41. PubMed ID: 35752805
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production.
Ouma C; Davenport GC; Were T; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Hum Genet; 2008 Dec; 124(5):515-24. PubMed ID: 18972133
[TBL] [Abstract][Full Text] [Related]
10. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
Anyona SB; Kempaiah P; Raballah E; Ouma C; Were T; Davenport GC; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
Infect Immun; 2011 Dec; 79(12):4923-32. PubMed ID: 21969001
[TBL] [Abstract][Full Text] [Related]
11. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.
Okeyo WA; Munde EO; Okumu W; Raballah E; Anyona SB; Vulule JM; Ong'echa JM; Perkins DJ; Ouma C
BMC Immunol; 2013 Mar; 14():15. PubMed ID: 23521898
[TBL] [Abstract][Full Text] [Related]
13. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
[TBL] [Abstract][Full Text] [Related]
14. Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children.
Achieng AO; Hengartner NW; Raballah E; Cheng Q; Anyona SB; Lauve N; Guyah B; Foo-Hurwitz I; Ong'echa JM; McMahon BH; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():290-302. PubMed ID: 31278068
[TBL] [Abstract][Full Text] [Related]
15. A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.
Ouma C; Keller CC; Davenport GC; Were T; Konah S; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Infect Immun; 2010 Jan; 78(1):453-60. PubMed ID: 19884328
[TBL] [Abstract][Full Text] [Related]
16. Complement component 3 mutations alter the longitudinal risk of pediatric malaria and severe malarial anemia.
Raballah E; Anyona SB; Cheng Q; Munde EO; Hurwitz IF; Onyango C; Ndege C; Hengartner NW; Pacheco MA; Escalante AA; Lambert CG; Ouma C; Obama HCJT; Schneider KA; Seidenberg PD; McMahon BH; Perkins DJ
Exp Biol Med (Maywood); 2022 Apr; 247(8):672-682. PubMed ID: 34842470
[TBL] [Abstract][Full Text] [Related]
17. Association analyses of NCR3 polymorphisms with P. falciparum mild malaria.
Delahaye NF; Barbier M; Fumoux F; Rihet P
Microbes Infect; 2007 Feb; 9(2):160-6. PubMed ID: 17208487
[TBL] [Abstract][Full Text] [Related]
18. Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo.
Baaklini S; Afridi S; Nguyen TN; Koukouikila-Koussounda F; Ndounga M; Imbert J; Torres M; Pradel L; Ntoumi F; Rihet P
PLoS One; 2017; 12(11):e0187818. PubMed ID: 29121672
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Severe malarial anemia: innate immunity and pathogenesis.
Perkins DJ; Were T; Davenport GC; Kempaiah P; Hittner JB; Ong'echa JM
Int J Biol Sci; 2011; 7(9):1427-42. PubMed ID: 22110393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
